Nexa Medical, Ltd.

Nexa Medical, Ltd. specializes in negative pressure wound therapy systems. Their primary device, the NEXA Negative Pressure Wound Therapy System, is designed to aid in wound healing for both acute and chronic wounds by applying controlled negative pressure. This technology is used in clinical settings to promote granulation tissue formation and improve healing outcomes.

Nexa Medical, Ltd. is headquartered in the United States. The company’s location ensures compliance with US regulatory standards, which govern the design, manufacturing, and distribution of its medical devices.

The NEXA Negative Pressure Wound Therapy System falls under Class II classification in the United States. Class II devices are considered to have an acceptable risk profile when properly controlled through general or special controls, such as performance standards or post-market surveillance, rather than requiring pre-market approval.

The NEXA Negative Pressure Wound Therapy System is listed in the FDA’s 510(k) database. This pathway is used for Class II devices that demonstrate substantial equivalence to a legally marketed predicate device, ensuring compliance with FDA requirements before commercial distribution.